StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer PP&E — Accumulated depreciation by Year

PP&E — Accumulated depreciation ($M) ($M)

Pfizer PP&E — Accumulated depreciation: $17,386M in FY2025, up 5.5% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
17,386
Period ended Dec 31, 2025
Change on a year earlier
+5.5%
16,483 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-K Property, Plant & Equipment Footnote.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPP&E — Accumulated depreciation ($M) ($M)Year on yearSource
FY2025Dec 31, 202517,386+5.5%Form 10-Q (filed 2026-08-04) ↗
FY2024Dec 31, 202416,483+2.7%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202316,045+5.7%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 202215,174+0.7%Form 10-K (filed 2024-02-22) ↗
FY2021Dec 31, 202115,074+2.8%Form 10-K (filed 2023-02-23) ↗
FY2020Dec 31, 202014,661-2.2%Form 10-K (filed 2022-02-24) ↗
FY2019Dec 31, 201914,990-9.6%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 201816,591+2.6%Form 10-K (filed 2020-02-27) ↗
FY2017Dec 31, 201716,172+9.2%Form 10-K (filed 2019-02-28) ↗
FY2016Dec 31, 201614,807+9.7%Form 10-K (filed 2018-02-22) ↗
FY2015Dec 31, 201513,502–Form 10-K (filed 2017-02-23) ↗

Cite this data

StockData. (2026). Pfizer PP&E — Accumulated depreciation ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/ppe-accum-dep

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.